These results also indicate that residual T levels of 0.2–2.94 ng/g and DHT levels of 0.36–2.19 ng/g, as measured in clinical tissues from CRPC patients, are sufficient to activate AR, stimulate AR-regulated genes and enable tumor cell growth and survival [13–15]. This evidence concerns the gene AR and neoplasm.